Abstract Details

Title Relapse rates among patients with multiple sclerosis who switch from interferon therapy to fingolimod or glatiramer acetate: a retrospective US claims database analysis

Topic Multiple Sclerosis

Presentation(s) (-)

Poster/Presentation
Number 211

Objective

Background

Design/Methods

Results

Conclusions

Authors/Disclosures
PRESENTER	No disclosure on file
Niklas Bergvall	No disclosure on file
	No disclosure on file
Neetu Agashivala (Novartis Pharmaceutical Corporation)	No disclosure on file
Ashish Pradhan, MD (Genentech)	Dr. Pradhan has received personal compensation for serving as an employee of Genentech. Dr. Pradhan has received stock or an ownership interest from Genetech.
Gorana Capkun	No disclosure on file
	No disclosure on file
	No disclosure on file
	No disclosure on file
	No disclosure on file
Charles Makin	No disclosure on file

��ɫ��

��ɫ��

Abstract Details

��ɫ����

��ɫ����

��ɫ��

��ɫ��